Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
15
CRI Quote, Financials, Valuation and Earnings
Last price:
$30.42
Seasonality move
:
-0.19%
Day range:
$29.67 - $31.08
52-week range:
$29.36 - $71.99
Dividend yield:
8.78%
P/E ratio:
6.68x
P/S ratio:
0.38x
P/B ratio:
1.30x
Volume:
1.4M
Avg. volume:
1.5M
1-year change:
-51.82%
Market cap:
$1.1B
Revenue:
$2.8B
EPS (TTM):
$4.52
Analysts' Opinion
-
Consensus RatingCarter's has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 3 Hold ratings, and 1 Sell rating.
-
Price Target DownsideAccording to analysts' consensus price target of $29.60, Carter's has an estimated downside of -1.99% from its current price of $30.20.
-
Price Target UpsideAccording to analysts, the highest upside price target is $33.00 representing -100% upside increase from its current price of $30.20.
Fair Value
-
According to the consensus of 4 analysts, Carter's has -1.99% downside to fair value with a price target of $29.60 per share.
CRI vs. S&P 500
-
Over the past 5 trading days, Carter's has underperformed the S&P 500 by -7.05% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Carter's does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Carter's revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Carter's reported revenues of $629.8M.
Earnings Growth
-
Carter's earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Carter's reported earnings per share of $0.43.
Enterprise value:
1.3B
EV / Invested capital:
--
Price / LTM sales:
0.38x
EV / EBIT:
5.47x
EV / Revenue:
0.45x
PEG ratio (5yr expected):
0.45x
EV / Free cash flow:
5.78x
Price / Operating cash flow:
4.83x
Enterprise value / EBITDA:
4.41x
Gross Profit (TTM):
$1.3B
Return On Assets:
6.92%
Net Income Margin (TTM):
5.8%
Return On Equity:
19.48%
Return On Invested Capital:
12.21%
Operating Margin:
4.14%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $3.1B | $2.9B | $2.8B | $661.5M | $629.8M | |
| Gross Profit | $1.4B | $1.4B | $1.3B | $315.2M | $291.1M | |
| Operating Income | $341.9M | $322.1M | $255.8M | $55M | $26.1M | |
| EBITDA | $380.2M | $400M | $289.8M | $72.7M | $42.4M | |
| Diluted EPS | $5.66 | $6.36 | $4.52 | $1.04 | $0.43 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.9B | $1.7B | $1B | $1B | $1B | |
| Total Assets | $3.3B | $3B | $2.3B | $2.3B | $2.3B | |
| Current Liabilities | $656.9M | $1B | $410.6M | $419M | $409.3M | |
| Total Liabilities | $2.3B | $2B | $1.5B | $1.4B | $1.5B | |
| Total Equity | $1B | $915.3M | $797.9M | $841.4M | $847.2M | |
| Total Debt | $990M | $991.8M | $576.8M | $497.5M | $498.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $294.4M | $461.4M | $275.7M | -$25.6M | -$48.6M | |
| Cash From Investing | -$46.5M | -$58.1M | -$54.5M | -$12M | -$10.3M | |
| Cash From Financing | -$790.6M | -$295.2M | -$163.1M | -$45.3M | -$33.6M | |
| Free Cash Flow | $247.8M | $403.3M | $221.2M | -$37.6M | -$59M | |
CRI
Sector
Market Cap
$1.1B
$426.2M
Price % of 52-Week High
41.95%
73.88%
Dividend Yield
8.78%
0%
Shareholder Yield
10.61%
4%
1-Year Price Total Return
-51.82%
-11.07%
Beta (5-Year)
0.986
0.767
Dividend yield:
8.78%
Annualized payout:
$3.20
Payout ratio:
71.06%
Growth streak:
1 years
Technicals
8-day SMA
Sell
Level
$31.85
200-day SMA
Sell
Level
$46.19
Bollinger Bands (100)
Sell
Level
31.07 - 40.91
Chaikin Money Flow
Sell
Level
-5.4M
20-day SMA
Sell
Level
$31.20
Relative Strength Index (RSI14)
Sell
Level
41.27
ADX Line
Sell
Level
13.4
Williams %R
Buy
Level
-86.5297
50-day SMA
Sell
Level
$32.38
MACD (12, 26)
Sell
Level
-0.12
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Sell
Level
-2.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.0938)
Buy
CA Score
(Annual)
Level (-0.1832)
Buy
Beneish M-Score
(Annual)
Level (-2.6312)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (0.4742)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.
Stock Forecast FAQ
In the current month, CRI has received 0 Buy ratings 3 Hold ratings, and 1 Sell ratings. The CRI average analyst price target in the past 3 months is $29.60.
-
Where Will Carter's Stock Be In 1 Year?
According to analysts, the consensus estimate is that Carter's share price will drop to $29.60 per share over the next 12 months.
-
What Do Analysts Say About Carter's?
Analysts are divided on their view about Carter's share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that Carter's is a Buy and believe this share price will rise from its current level to $33.00.
-
What Is Carter's's Price Target?
The price target for Carter's over the next 1-year time period is forecast to be $29.60 according to 4 Wall Street analysts, 0 of them rate the stock a Buy, 1 rates the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is CRI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Carter's is a Hold. 3 of 4 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CRI?
You can purchase shares of Carter's via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Carter's shares.
-
What Is The Carter's Share Price Today?
Carter's was last trading at $30.42 per share. This represents the most recent stock quote for Carter's. Yesterday, Carter's closed at $30.20 per share.
-
How To Buy Carter's Stock Online?
In order to purchase Carter's stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
